Abstract:Purpose: Recent animal studies suggest that activation of Wnt/β-catenin signaling in articular chondrocytes might be a driving factor in the pathogenesis of osteoarthritis (OA) by stimulating amongst others the expression of matrix metalloproteinases (MMPs). Indeed in animal chondrocytes IL-1β induced MMP expression is mediated by activation of canonical Wnt/β-catenin signaling. This study aimed to investigate the role of Wnt/β-catenin signaling in IL-1β induced MMP expression in human chondrocytes. Methods: Primary cultures of human articular chondrocytes derived from post mortem healthy donors or patients with end stage osteoarthritis or rheumatoid arthritis were used in all experiments. Cells were stimulated with recombinant growth factors and cytokines. Changes in gene and protein expression were studied using qPCR, Western blot, and enzymatic essays. Multiple strategies for activation and inhibition of signaling pathways in human chondrocytes, such as lentiviral mediated gene overexpression or gene knock down were used. Luciferase reporter assays and co-immunoprecipitation essays were used to study the interaction between β-catenin and NF-κB. Results: IL-1β potently stimulated MMP1, -3 and -13 expression in human and murine chondrocytes dose-dependently. In marked contrast, co-stimulation with the recombinant Wnt3A, which activates canonical Wnt/β-catenin signaling, potently inhibited IL-1β induced MMP dose-dependently in human chondrocytes but not in murine chondrocytes. This inhibitory effect was found in human chondrocytes irrespective of the disease state of the donor being either healthy, osteoarthritic or rheumatoid arthritic and was also found in human bone marrow derived mesenchymal stem cells. In contrast, Wnt/β-catenin signaling induced MMP expression in chondrocytes of all animal species tested, revealing an unprecedented species difference. Wnt3A's inhibitory effect was found in both basal conditions and after IL-1β stimulation at the mRNA level, protein level and in enzymatic essays. Wesetern blot indicated that IL-1β indirectly activated β-catenin in human chondrocytes. This was due to IL-1β induced upregulation of the canonical Wnt7B and down regulation of the Wnt-signaling antagonists DKK1, Wif1 and FRZb as demonstrated by gene knock down and gene overexpression studies. The inhibitory effect of Wnt3A on IL-1β induced MMP expression was independent of TCF/LEF transcription factors, since knock down of TCF4 did not alter Wnt3A's effect. This was in marked contrast to murine chondrocytes in which knock down of TCF4 completely blocked IL-1β induced MMP expression. Subsequently, we showed that the inhibitory effect on IL-1β induced MMP expression in human chondrocytes was due to an inhibitory protein-protein interaction between β-catenin and NF-κB/p65RELA blocking the activation of NF-κB promoter reporter constructs as well as inhibiting the expression of established NF-κB target genes like IL-6. Conclusions: Our study reveals an unexpected and unprecedented species difference between human and animal chondrocytes with respect of the role of Wnt/β-catenin signaling in the regulation of MMP expression. In marked contrast to mouse chondrocytes in which Wnt/β-catenin signaling is part of an IL-1β activated pro-catabolic sequence resulting in increased MMP expression, in human cells β-catenin has an unexpected anti-catabolic role. We provide evidence that Wnt/β-catenin signaling is part of an IL-1β activated negative feedback loop involving upregulation of the canonical Wnt7B and down regulation of established Wnt-antagonists like DKK1. This leads to activation of β-catenin, which in turn inhibits NF-κB activity due to an inhibitory protein-protein interaction with p65RELA. Our results question the relevance of animal models for studying the role of Wnt/β-catenin signaling in osteoarthritis. They furthermore imply that upregulated β-catenin in human osteoarthritic cartilage may be part of an anti-catabolic response counteracting pro-catabolic NF-κB signaling.

A Wnt/β-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes.

A WNT/β-catenin Negative Feedback Loop Inhibits IL-1β Induced Mmp Expression in Human Articular Chondrocytes

Activation of the P38/CREB/MMP 13 Axis is Associated with Osteoarthritis

Wnt/β-catenin and Hedgehog Pathways Are Involved in the Inflammatory Effect of Interleukin 18 on Rat Chondrocytes

Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.

Inhibition of Beta-Catenin Signaling in Articular Chondrocytes Results in Articular Cartilage Destruction

Requirement of the NF-κB pathway for induction of Wnt-5A by interleukin-1β in condylar chondrocytes of the temporomandibular joint: functional crosstalk between the Wnt-5A and NF-κB signaling pathways.

Role of TCF4 in Signaling Crosstalk with NFκB in Human Chondrocytes

Wnt/β‑catenin Signaling May Induce Senescence of Chondrocytes in Osteoarthritis

Overexpression of HMGB1 A-box Reduced IL-1β-induced MMP Expression and the Production of Inflammatory Mediators in Human Chondrocytes.

The Antagonistic Actions of Endogenous Interleukin-1β and 15-Deoxy-δ12,14-prostaglandin J2 Regulate the Temporal Synthesis of Matrix Metalloproteinase-9 in Sheared Chondrocytes

Follistatin‐like Protein 1 (FSTL1) Promotes Chondrocyte Expression of Matrix Metalloproteinase and Inflammatory Factors Via the NF‐κB Pathway

Wnt/ Beta -Catenin Signaling in the Pathogenesis of Osteoarthritis

The Nrf2/HMGB1/NF-κB axis modulates chondrocyte apoptosis and extracellular matrix degradation in osteoarthritis

The Role of Cyclooxygenase-2, Interleukin-1β and Fibroblast Growth Factor-2 in the Activation of Matrix Metalloproteinase-1 in Sheared-Chondrocytes and Articular Cartilage

A2M Inhibits Inflammatory Mediators of Chondrocytes by Blocking IL‐1β/NF‐κB Pathway

MiRNA-140 is a Negative Feedback Regulator of MMP-13 in IL-1β-stimulated Human Articular Chondrocyte C28/I2 Cells

The Mir-302C/transforming Growth Factor-Β Receptor Type-2 Axis Modulates Interleukin-1Β-induced Degenerative Changes in Osteoarthritic Chondrocytes

Effects of Wnt3A and mechanical load on cartilage chondrocyte homeostasis

Changes of type II collagenase biomarkers on IL-1-induced rat articular chondrocytes

Interleukin-1β and Tumor Necrosis Factor-Α Increase Stiffness and Impair Contractile Function of Articular Chondrocytes